Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
or

Aldeyra Therapeu (ALDX)

Aldeyra Therapeu (ALDX)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
6.91 +0.10 (+1.47%) 03/14/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 6.80 -0.11 (-1.59%) 19:56 ET
Quote Overview for Fri, Mar 14th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
6.81
Day High
7.08
Open 6.83
Previous Close 6.81 6.81
Volume 581,800 581,800
Avg Vol 636,795 636,795
Stochastic %K 87.60% 87.60%
Weighted Alpha +84.69 +84.69
5-Day Change +0.56 (+8.82%) +0.56 (+8.82%)
52-Week Range 2.71 - 7.20 2.71 - 7.20
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 406,618
  • Shares Outstanding, K 59,709
  • Annual Sales, $ 0 K
  • Annual Income, $ -55,850 K
  • EBIT $ -60 M
  • EBITDA $ -62 M
  • 60-Month Beta 1.24
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 5.85

Options Overview Details

View History
  • Implied Volatility 131.35% ( -36.39%)
  • Historical Volatility 90.33%
  • IV Percentile 84%
  • IV Rank 34.74%
  • IV High 312.88% on 08/06/24
  • IV Low 34.71% on 06/25/24
  • Put/Call Vol Ratio 0.34
  • Today's Volume 717
  • Volume Avg (30-Day) 1,388
  • Put/Call OI Ratio 0.36
  • Today's Open Interest 30,613
  • Open Int (30-Day) 30,002

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.25
  • Number of Estimates 2
  • High Estimate -0.24
  • Low Estimate -0.25
  • Prior Year -0.14
  • Growth Rate Est. (year over year) -78.57%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.78 +44.56%
on 02/28/25
Period Open: 6.49
7.20 -4.03%
on 03/12/25
+0.42 (+6.47%)
since 02/14/25
3-Month
4.66 +48.28%
on 01/13/25
Period Open: 4.90
7.20 -4.03%
on 03/12/25
+2.01 (+41.02%)
since 12/13/24
52-Week
2.71 +154.98%
on 03/15/24
Period Open: 2.77
7.20 -4.03%
on 03/12/25
+4.14 (+149.46%)
since 03/14/24

Most Recent Stories

More News
Is the Options Market Predicting a Spike in Aldeyra Therapeutics (ALDX) Stock?

Investors in Aldeyra Therapeutics, Inc. ALDX need to pay close attention to the stock based on moves in the options market lately. That is because the March 3, 2025 $2.50 Call had some of the highest implied...

ALDX : 6.91 (+1.47%)
10 Stocks Retailers Are Most Bullish/Bearish About On Tuesday

Earnings have largely impacted sentiment toward stocks that made it to the most bullish and bearish lists on Stocktwits Tuesday.

ALDX : 6.91 (+1.47%)
STIM : 4.52 (+2.49%)
PGY : 10.56 (+9.20%)
QSI : 1.3600 (+19.30%)
MNOV : 1.5500 (+5.44%)
AXSM : 121.91 (+0.21%)
VSAT : 9.85 (+5.01%)
ZS : 197.81 (+4.34%)
BTM : 1.3700 (+3.79%)
RVPH : 1.1100 (+6.73%)
SPY : 562.81 (+2.07%)
XBI : 87.13 (+1.35%)
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders of a Class Action against Aldeyra Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - ALDX

/PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Aldeyra Therapeutics, Inc. ("Aldeyra" or the "Company") (NASDAQ:...

ALDX : 6.91 (+1.47%)
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Aldeyra Therapeutics, Inc.(ALDX) Investors of a Class Action Lawsuit and Upcoming Deadline

/PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Aldeyra Therapeutics, Inc. ("Aldeyra" or the "Company") (NASDAQ: ALDX) of a class action securities...

ALDX : 6.91 (+1.47%)
ALDX Investors Have Opportunity to Lead Aldeyra Therapeutics, Inc. Securities Fraud Lawsuit

/PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action...

ALDX : 6.91 (+1.47%)
Final Deadline Alert: ALDX Investor Alert: Contact Bronstein, Gewirtz & Grossman, LLC to Actively Participate in the Aldeyra Therapeutics, Inc. Class Action Lawsuit

/PRNewswire/ -- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has...

ALDX : 6.91 (+1.47%)
ALDX FINAL DEADLINE ALERT: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Aldeyra Therapeutics, Inc. Investors to Secure Counsel Before Important September 29 Deadline in Securities Class Action - ALDX

/PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) between...

ALDX : 6.91 (+1.47%)
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders of a Class Action against Aldeyra Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - ALDX

/PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Aldeyra Therapeutics, Inc. ("Aldeyra" or the "Company") (NASDAQ:...

ALDX : 6.91 (+1.47%)
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Aldeyra Therapeutics, Inc.(ALDX) Investors of a Class Action Lawsuit and Upcoming Deadline

/PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Aldeyra Therapeutics, Inc. ("Aldeyra" or the "Company") (NASDAQ: ALDX) of a class action securities...

ALDX : 6.91 (+1.47%)
ALDX Investors Have Opportunity to Lead Aldeyra Therapeutics, Inc. Securities Fraud Lawsuit

/PRNewswire/ -- Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action...

ALDX : 6.91 (+1.47%)

Business Summary

Aldeyra Therapeutics, Inc. is a biotechnology company. The company's products target immune-mediated, inflammatory, orphan, and other diseases. It is developing NS2, a compound that binds and traps free aldehydes. Aldeyra Therapeutics, Inc. is based in Burlington, Massachusetts.

See More

Key Turning Points

3rd Resistance Point 7.33
2nd Resistance Point 7.20
1st Resistance Point 7.06
Last Price 6.91
1st Support Level 6.79
2nd Support Level 6.66
3rd Support Level 6.52

See More

52-Week High 7.20
Last Price 6.91
Fibonacci 61.8% 5.48
Fibonacci 50% 4.95
Fibonacci 38.2% 4.43
52-Week Low 2.71

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Precision Trading with Bollinger Bands: Identifying Breakouts & Reversals